These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3376967)

  • 1. Osmolality of oral drug solutions and suspensions.
    Dickerson RN; Melnik G
    Am J Hosp Pharm; 1988 Apr; 45(4):832-4. PubMed ID: 3376967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osmolality of substances used in the intensive care nursery.
    Ernst JA; Williams JM; Glick MR; Lemons JA
    Pediatrics; 1983 Sep; 72(3):347-52. PubMed ID: 6889039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osmolality of small-volume i.v. admixtures for pediatric patients.
    Santeiro ML; Sagraves R; Allen LV
    Am J Hosp Pharm; 1990 Jun; 47(6):1359-64. PubMed ID: 2368732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration.
    de Lemos ML; Monfared S; Denyssevych T; Hamata L; Jennings S; Thiessen B; Smith S; Waterhouse D
    J Oncol Pharm Pract; 2009 Mar; 15(1):45-52. PubMed ID: 18772215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osmolality of small-volume intravenous admixtures.
    Wermeling DP; Rapp RP; DeLuca PP; Piecoro JJ
    Am J Hosp Pharm; 1985 Aug; 42(8):1739-44. PubMed ID: 4036971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osmolality of solutions, emulsions and drugs that may have a high osmolality: aspects of their use in neonatal care.
    Pereira-da-Silva L; Henriques G; Videira-Amaral JM; Rodrigues R; Ribeiro L; Virella D
    J Matern Fetal Neonatal Med; 2002 May; 11(5):333-8. PubMed ID: 12389676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osmolality electrolyte and carbohydrate type and oral rehydration solutions: a controlled study to compare the efficacy of two commercially available solutions (osmolalities 240 mmol/L and 340 mmol/L).
    Wall CR; Shepherd RW; Patrick M; Chin S; Cleghorn G
    J Diarrhoeal Dis Res; 1993 Dec; 11(4):222-6. PubMed ID: 8188994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal disorders caused by medication and electrolyte solution osmolality during enteral nutrition.
    Niemiec PW; Vanderveen TW; Morrison JI; Hohenwarter MW
    JPEN J Parenter Enteral Nutr; 1983; 7(4):387-9. PubMed ID: 6413718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability and osmolality of a nutritional food supplement during simulated nasogastric administration.
    Galt LG; Josephson RV
    Am J Hosp Pharm; 1982 Jun; 39(6):1009-12. PubMed ID: 6808833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osmolality of Commonly Used Oral Medications in the Neonatal Intensive Care Unit.
    Shah DD; Kuzmov A; Clausen D; Siu A; Robinson CA; Kimler K; Meyers R; Shah P
    J Pediatr Pharmacol Ther; 2021; 26(2):172-178. PubMed ID: 33603581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypertonic solutions and intracranial pressure].
    Favre JB; Ravussin P; Chiolero R; Bissonnette B
    Schweiz Med Wochenschr; 1996 Sep; 126(39):1635-43. PubMed ID: 8927967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of sulfadiazine oral liquids prepared from tablets and powder.
    Pathmanathan U; Halgrain D; Chiadmi F; Schlatter J; Vermerie N
    J Pharm Pharm Sci; 2004 Apr; 7(1):84-7. PubMed ID: 15144740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a new tear osmometer for repeatability and accuracy, using 0.5-microL (500-Nanoliter) samples.
    Yildiz EH; Fan VC; Banday H; Ramanathan LV; Bitra RK; Garry E; Asbell PA
    Cornea; 2009 Jul; 28(6):677-80. PubMed ID: 19512902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Osmolality of products and formulas for nutritional therapy].
    De Abreu J; López E; Dini E
    Invest Clin; 2009 Dec; 50(4):433-45. PubMed ID: 20306717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osmotic strength, osmolality, and osmolarity.
    Deardorff DL
    Am J Hosp Pharm; 1980 Apr; 37(4):504-9. PubMed ID: 6990751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osmotherapy with hypertonic saline attenuates water content in brain and extracerebral organs.
    Toung TJ; Chen CH; Lin C; Bhardwaj A
    Crit Care Med; 2007 Feb; 35(2):526-31. PubMed ID: 17205030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
    Bozdağ S; Gümüş K; Gümüş O; Unlü N
    Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of reconstituted fluconazole oral suspension in plastic bottles and oral syringes.
    Dentinger PJ; Swenson CF
    Ann Pharmacother; 2009 Mar; 43(3):485-9. PubMed ID: 19208778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical properties of soft contact lens solutions.
    Dalton K; Subbaraman LN; Rogers R; Jones L
    Optom Vis Sci; 2008 Feb; 85(2):122-8. PubMed ID: 18296929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.